Shineway Pharm (02877) announced interim results
- RevenueRMB11.8bn
- Net profitRMB4.7bn
- Profit attributable to ownersRMB4.7bn
- Revenue YoY-28.5%
- Net profit YoY-23.7%
- Depreciation & amortisationHK$70.9M
- Capital expenditureHK$-2.0bn
- Interest-bearing debtHK$3.3bn
Source Shineway Pharm



